Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VNDA
Stock Latest News
The Fly
Vanda trading resumes
2d ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals announces FDA approval of Bysanti tablets
2d ago
VNDA
Premium
The Fly
Vanda trading halted, news pending
2d ago
VNDA
Premium
Company Announcements
Vanda Board Approves 2025 Bonuses and 2026 Compensation
3d ago
8K
VNDA
Premium
Market News
FDA Calendar: Vanda Stock (VNDA) Shows 125% Upside with Bysanti Decision on Deck
3d ago
VNDA
Premium
Company Announcements
Regulatory Hurdles Cloud Vanda Pharmaceuticals’ Prospects for Bysanti and Imsidolimab FDA Approvals
10d ago
VNDA
Premium
Company Announcements
Vanda Pharmaceuticals Balances Growth With Rising Risks
10d ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals files $200M mixed securities shelf
11d ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals reports Q4 EPS ($2.39) vs. (8c) last year
11d ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals sees FY26 revenue $230M-$260M, consensus $271.27M
11d ago
VNDA
Premium
Pre-Earnings
VNDA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
14d ago
VNDA
Premium
Company Announcements
Vanda Pharmaceuticals Advances Ponesimod Into Phase 3 Psoriasis Study: What Investors Should Know
1M ago
VNDA
Premium
Ratings
Maintaining Buy Rating on Vanda: Limited Impact from Tasimelteon Setback, Ongoing FDA Engagement, and Bysanti Catalyst Support $22 Target
2M ago
VNDA
Premium
The Fly
H.C. Wainwright says rejection of Vanda’s tasimelteon ‘only minor setback’
2M ago
VNDA
Premium
Company Announcements
Vanda Faces FDA Setback on HETLIOZ Jet Lag Application
2M ago
8K
VNDA
Premium
The Fly
Vanda Pharmaceuticals down 11% to $7.55 after FDA rejects sNDA for hetlioz
2M ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals: FDA says sNDA for hetlioz can’t be approved
2M ago
VNDA
Premium
The Fly
Vanda Pharmaceuticals price target raised to $22 from $20 at H.C. Wainwright
2M ago
VNDA
Premium
The Fly
Midday Fly By: Nvidia said to see strong H200 demand in China
2M ago
CSX
DJT
Premium
The Fly
Morning Movers: Nvidia up as report points to strong demand in China
2M ago
H
NKE
Premium
The Fly
Video: Nvidia responding to strong demand for H200 in China
2M ago
NKE
NVDA
Premium
The Fly
Vanda Pharmaceuticals price target raised to $14 from $11 at B. Riley
2M ago
VNDA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
